GPT-Rosalind (OpenAI)
C Tier · 6.8/10
**Since 2026-10-15 US university labs can apply for the Rosalind Academic Plan: up to 30 ChatGPT Business Standard seats free for up to 12 months, with GPT-Rosalind and Rosalind Workbench behind trusted-access approval.** OpenAI's first domain-specific model -- life sciences, drug discovery, translational medicine. Launched 2026-04-16 as a Trusted Access research preview. Launch partners: Amgen, Moderna, Allen Institute, Thermo Fisher. Paired with a Life Sciences Codex plugin (50+ scientific tool integrations)
Score Breakdown
The Good and the Bad
What we like
- +Since 2026-10-15 a vetted US university lab can get GPT-Rosalind at no cost: the Rosalind Academic Plan gives up to 30 Business Standard seats free for up to 12 months, with the other frontier OpenAI models included
- +OpenAI's first named vertical/domain-specific model -- signals a new strategy beyond general-purpose GPT-5.x. The pattern (vertical + gated rollout + blue-chip launch partners) echoes the 2026-04-07 Anthropic Mythos Preview / Project Glasswing model and suggests how frontier-lab productization will work in 2026 and beyond
- +Launch partners Amgen, Moderna, Allen Institute, Thermo Fisher are credible biotech and research institutions -- not just splashy logos. Suggests the model has been meaningfully trained/tuned on real biology data with real domain expertise in the loop
- +Life Sciences Codex plugin is the practical hook -- 50+ scientific tool integrations (PubMed, BioRxiv, UniProt, scientific Python libraries) mean Codex can now run multi-step research workflows: literature search, protein lookup, reagent ordering scripts, experimental design in one chain
- +OpenAI is now playing in the space Anthropic's Mythos targets (gated domain models) with Nvidia's vertical strategy (BioNeMo, Evo) and Google's Med-PaLM lineage. Competition drives rapid improvement
What could be better
- −Not available to anyone reading this unless your org is already a Trusted Access partner. If you are at Amgen or Moderna, ask internally. Everyone else: wait and see
- −Domain-specific model, so for general-purpose work Claude Opus 5.5, GPT-6 or Gemini 4 Argon remain the right answer -- GPT-Rosalind will be narrower in scope even once broadly available
- −Trusted Access means OpenAI controls who uses it. Unlike consumer ChatGPT, there is no path from 'I am curious' to 'I am using it' without an enterprise sales conversation
- −Claims need third-party verification. At launch, OpenAI has not published open benchmarks. Expect published drug-discovery / biology evals from neutral sources over next 3-6 months
Pricing
Rosalind Academic Plan (from 2026-10-15)
- ✓US university labs only; the PI or lab lead applies and OpenAI vets the institution, the lead and the intended use
- ✓GPT-Rosalind access subject to trusted-access approval, plus all commercially available frontier OpenAI models within plan limits
- ✓Rosalind Workbench tool orchestration (medicinal chemistry, genomics, wet-lab assistance)
- ✓No API access; research data not used for training by default; universities with an OpenAI Enterprise agreement apply through it
Trusted Access (gated)
- ✓Research preview limited to partner organizations
- ✓Launch partners: Amgen, Moderna, Allen Institute for Cell Science, Thermo Fisher
- ✓Application required via OpenAI enterprise sales
- ✓Not available to consumer ChatGPT users
Life Sciences Codex Plugin
- ✓50+ scientific tool integrations (PubMed, BioRxiv, UniProt, etc.)
- ✓Works with Codex cloud agent for multi-step research workflows
- ✓Available in ChatGPT Pro ($100/mo) and Business tiers
Public access
- ✓Not being released publicly as a standalone product
- ✓Consumer use case unclear -- this is an enterprise / research tool
Known Issues
- ROSALIND ACADEMIC PLAN -- FREE SEATS FOR US ACADEMIC LABS, STILL BEHIND TRUSTED ACCESS (2026-10-15, vendor-primary): OpenAI introduced the Rosalind Academic Plan 'to help more academic scientists access GPT-Rosalind, our dedicated life sciences model, which combines frontier reasoning with Rosalind workbench that enables specialized tool orchestration across medicinal chemistry, genomics, wet-lab assistance, and other scientific applications'. **Terms:** 'Up to 30 Business Standard seats at $0 per user per month for up to 12 months'; 'Access to all commercially available frontier OpenAI models, subject to plan usage limits'; research data 'not used to train our models by default'; 'API access is not included at this time.' **Eligibility:** 'currently available to academic labs at U.S. universities'; PIs and lab leads at universities without an Enterprise agreement apply through OpenAI's trusted access process, those with one go through the university. OpenAI verifies the institution and the lead's identity and appointment and reviews research activities and intended use; applying 'doesn't give your lab immediate access'. Quoted users include labs at UCSF. **What changed for this page:** GPT-Rosalind is no longer limited to a handful of named enterprise partners -- a vetted academic lab can now get it at no cost -- but it is still not self-serve and there is still no public benchmark or consumer access. Separately, OpenAI's Enterprise token rate card (early October) lists GPT-Rosalind-Research for select Enterprise plans (see the ChatGPT page).Source: OpenAI (openai.com/index/introducing-the-rosalind-academic-plan/, publicationDateText 'October 15, 2026') + ChatGPT release notes 'October 15, 2026' -- fetched 2026-10-15 via curl with browser UA · 2026-10-15
- Trusted Access rollout -- not open for self-serve signup. Launched 2026-04-16 with fewer than 10 named partners. Broader access timeline not announcedSource: OpenAI launch post · 2026-04
- No independently-published benchmark results yet. OpenAI's claims (life-science reasoning superiority over general-purpose GPT-5.x) rely on internal evaluations. Wait for neutral published comparisons over Q2/Q3 2026Source: VentureBeat, OpenAI launch coverage · 2026-04
Best for
Researchers and enterprises in biology, drug discovery, protein science, translational medicine, or adjacent life-sciences domains who can get Trusted Access. Also relevant to anyone building life-sciences AI products who needs to understand where OpenAI's vertical strategy is heading.
Not for
General-purpose use (use GPT-6, Claude Opus 5.5 or Gemini 4 Argon). Consumer users outside a partner org or an approved US academic lab (no self-serve access). Anyone expecting standalone consumer pricing -- this is an enterprise / research play only.
Our Verdict
GPT-Rosalind is OpenAI's first named vertical model, launched 2026-04-16 as a Trusted Access preview with Amgen, Moderna, Allen Institute, and Thermo Fisher as launch partners. The parallel to Anthropic's Mythos Preview (2026-04-07) is clear: frontier labs are shipping gated domain-specific models while keeping their general-purpose models (GPT-5.x, Opus 4.x) publicly accessible. For life-sciences researchers in those partner orgs, this is a real capability upgrade worth exploring. For everyone else, it is a strategic signal: expect GPT-[domain] models in law, finance, defense, and other verticals through 2026, and expect broad availability never to materialize for the most capable tiers. The bundled Life Sciences Codex plugin (50+ scientific tool integrations) is the more immediately actionable item -- ChatGPT Pro and Business users can run multi-step life-sciences research workflows with it starting today.
Sources
- OpenAI: Bringing GPT-Rosalind to academic research labs -- Rosalind Academic Plan (2026-10-15) (accessed 2026-10-15)
- OpenAI ChatGPT release notes -- October 15, 2026: applications for the Rosalind Academic Plan (accessed 2026-10-15)
- OpenAI: Introducing GPT-Rosalind (accessed 2026-04-17)
- VentureBeat: OpenAI debuts GPT-Rosalind + Codex plugin (accessed 2026-04-17)
- Industry analysis of vertical AI strategy (accessed 2026-04-17)
Explore more GPT-Rosalind (OpenAI) rankings
Deeper leaderboards, benchmarks, task-specific tier lists, and status/pricing pages for GPT-Rosalind (OpenAI).
The Tier List Tuesday
Weekly newsletter: tier movers, new entrants, and the VS of the week. Built from our daily AI-tool sweeps. No spam, unsubscribe anytime.
Alternatives to GPT-Rosalind (OpenAI)
Claude (Anthropic)
**Claude Haiku 5.5 shipped on 2026-10-07 at $0.10 / $0.50 per 1M tokens for prompts up to 100K ($0.50 / $2.50 above) -- 90% below Haiku 4.5 on most requests -- with adjustable effort for the first time on a Haiku, and the same day Anthropic halved Sonnet 5.5 cache reads to $0.10 and added monthly API credits for Max ($100 or $200) and Team (up to $500 pooled).** **Anthropic expanded the Cyber Verification Program on 2026-10-06 into three access tiers (Defense, Red Team, Specialized) that unlock reduced cyber safeguards on Opus 5.5, Sonnet 5.5, Mythos 5.1 and future models for verified security teams -- closing the 'coming weeks' note Opus 5.5 shipped with; generally available Claude keeps its conservative cyber blocks.** **Two Claude 5.5 models in six days: Claude Opus 5.5 (2026-09-22) and Claude Sonnet 5.5 (2026-09-28).** Opus 5.5 performs at Fable 5.1 level on most work and costs 40% less than Opus 5 to run -- $4/$20 per 1M (down from $5/$25) with cache reads cut to $0.20 (from $0.50), fast mode at $8/$40 up to 2.5x speed, output 30%+ faster, and five-hour usage limits raised on Pro, Max, Team and seat-based Enterprise with a saveable rate-limit reset. Sonnet 5.5 keeps Sonnet 5's $2/$10 but needs far fewer tokens (up to 30% cheaper per task), runs 30%+ faster and jumps Terminal-Bench 4.0 from 10.3% to 70.6%. Both are 1M context, Jun 2026 cutoff, on the Claude Platform, Bedrock, Vertex and Foundry; Haiku 5.5 followed on 2026-10-07. Opus 5.5 launches with Fable-class cyber and bio safeguards (most cyber tasks fall back to Opus 4.8) and cannot run with thinking off.
Claude Mythos 5.1
**From 2026-10-06 Mythos 5.1 is included in every tier of Anthropic's expanded Cyber Verification Program, and existing Project Glasswing members move into its Specialized Access tier without reapproval -- with the first disclosed Glasswing numbers: at least 129,000 verified vulnerabilities found April-July 2026, more than 33,000 rated critical or high.** Anthropic's trusted-access frontier model. **Mythos 5.1 launched 2026-09-01** alongside Fable 5.1, and Anthropic now states outright that they are **the same model with different safeguards** -- the 5.1-cycle gap is 60.9% vs 55.8% on Terminal-Bench 4.0, which Anthropic attributes to safeguard interventions rather than capability and expects to shrink. Originally launched June 9, 2026 alongside Claude Fable 5. Suspended June 12 by a US export-control order, then PARTIALLY RESTORED July 1, 2026 (US government lifted controls June 30): Mythos 5 is back for a set of US organizations with government approval, while Anthropic works to re-expand the broader Glasswing program. Public Fable 5 returned globally the same day. Gated to Project Glasswing orgs + select biology researchers.
Gemini (Google)
**Gemini 4 Argon went generally available on 2026-10-13: in the Gemini API (paid tier only), AI Studio, Gemini for business and GitHub Copilot, in the Gemini app and AI Mode in Search for Google AI Pro and Ultra subscribers, and in Google Antigravity for Ultra. The API rate card prices it at $2 input / $10 output per 1M tokens with $0.10 implicit-cache reads through November 30, 2026, doubling to $4 / $20 / $0.20 on December 1; there is no free tier and no explicit caching.** Google calls it its flagship reasoning model, with a 1M-token unified input-output limit, #1 on the Vals Index, 87% on the ERQA embodied-reasoning benchmark and 0.7% attack success on Gray Swan prompt injection, alongside the 9/30 numbers (77.9% DeepSWE v1.1, 51.3% AutomationBench, 91.7% LVBench, 68% CWE-bench v1) -- all vendor-reported. Earlier in October: Gemini 3.7 Flash and 3.5 Flash were retired from AI Studio (10/08) with API calls auto-routed to 3.8 Flash and 3.6 Flash, Nano Banana 2.1 went GA (10/06) and SynthID Detector opened to everyone in English (10/07). Late September in the Gemini app: **skills replace Gems** (9/30; slash-command instructions with reference files, Gems removed from November 2026 for personal accounts), **Guided Vision in Gemini Live** for blind and low-vision users on Android (10/01), and the 9/23-9/24 wave still stands: Gemini 3.8 Flash TTS and Flash-Lite TTS with voice design at $0.50/$9.00 and $0.50/$6.00 per 1M (doubling 2027-01-01), Gemini 3.8 Live with Live Avatar in Gemini Enterprise, free 1080p Omni 1.1 video in Google Vids. Googlebook was scheduled to reach shelves 10/04 (shipment not yet vendor-confirmed).
Grok
**The X Subscription (2026-10-12) folds Grok, Grok Bot, Cursor and X Premium into one plan: Free, Plus $8, Premium $30 (what SuperGrok, Cursor Pro and X Premium+ cost $90 for combined), Super $100 and Ultra $200 a month, with one weekly-refreshing usage pool shared across Grok and Cursor; the old SuperGrok, Cursor and X Premium plans are closed to new sign-ups.** **Team Bots launched 2026-09-28 in public beta on Teams and Enterprise plans** -- shared Grok Bots built around a role, with team context (files, instructions, skills), plugins (Salesforce, Notion, GitHub), credentials for APIs without a plugin, and memories, where the bot is shared but each person's conversations and memories stay private; each Team Bot gets its own Slack handle. SpaceXAI runs one per major sales account, and its 9/22 case study says the merged SpaceXAI + Cursor support desk absorbed a 175% ticket increase on Grok Bot with no new hires at $0.20-$0.30 per resolution. **Grok 4.7 (9/21)** remains the flagship at $2/$6 per 1M with chart-only benchmarks; Grok Voice Transcribe 2.0 and the corrected $15/1M-character TTS price stand.
Muse Spark + Muse Wonder (Meta)
Meta Superintelligence Labs' model family, now four lines deep: **Muse Wonder** (2026-10-12, frontier, $4/$20 per 1M on the Meta Model API; Wonder Full only in Muse Code subscriptions), **Muse Spark 1.3** (2026-09-02, $1.25/$4.25, or $0.10/$0.20 in Contributor mode if Meta may train on your content), **Muse Spark Open** (2026-10-15, 816B/42B-active open weights, 1M context, runs on two Mac Studios with M5 Ultra) and **Muse Glimmer** (2026-08-10, 30B, Apache 2.0, built for local agents). Consumers get it through **Muse**, Meta's personal-agent app (2026-09-08): free with limits, Power $20/mo, Maximum $100/mo
GPT-5.6-Cyber / GPT-5.4-Cyber (OpenAI)
**GPT-5.4-Cyber reached its API removal date on 2026-10-01: the gpt-5.4-cyber model page now returns Not found while gpt-5.6-cyber stays live (checked 2026-10-02; OpenAI's deprecations doc had not yet moved the row to Past Deprecations). Its replacement is `gpt-5.6-cyber`**, an alias for OpenAI's most advanced purpose-trained cyber models, gated behind the Daybreak program and priced at $12.50/$75 per 1M (first published price for any OpenAI cyber model). Original page: OpenAI's defensive-cybersecurity variant of GPT-5.4, launched 2026-04-16. Lowered refusal boundary for security-research tasks and native binary reverse-engineering. Access gated via Trusted Access for Cyber (TAC) program -- thousands of verified defenders, hundreds of teams, no public pricing. On **2026-08-17 OpenAI published its first dedicated post on the Hugging Face incident**, conceding it 'underestimated the real-world cyber capabilities of our AI models' and confirming it now releases cyber capabilities only to trusted defenders. **On 2026-09-01 OpenAI confirmed GPT-6 Astra meets the Critical cyber threshold -- the first model it has ever designated at that level -- and on 2026-09-03 committed $1B to Daybreak for Frontline Defenders**
Microsoft MAI-Thinking-1
Microsoft's first in-house reasoning model -- launched 2026-06-02 at Build as the flagship of seven new MAI models. 35B-active / ~1T-total sparse Mixture-of-Experts, 256K context. AIME 2025 97.0%, matches leading models on SWE-Bench Pro, and beat Claude Sonnet 4.6 in human-preference testing. Available on Microsoft Foundry + OpenRouter / Fireworks / Baseten
Hunyuan 3 (Tencent Hy3)
Tencent's Hy3 reached GA 2026-07-06 (upgraded from the April preview) -- 295B total / 21B active MoE, 256K context, now Apache 2.0 open weights on HuggingFace + ModelScope with the EU/UK/South Korea restriction lifted. ~90% agent-task completion on Tencent's internal apps; API via Tencent Cloud TokenHub. Integrated into Yuanbao, WeChat, QQ
MiMo (Xiaomi)
Xiaomi's MiMo-V2.5 family launched 2026-04-22 -- Pro (1T total / 42B active MoE, 1M context, native vision+audio reasoning), Multimodal base, TTS (3 sub-models: base, VoiceDesign, VoiceClone), and ASR (open-source, English + Chinese + major dialects). Full voice pipeline for the agent era. Extra-charge 1M-context tier removed at launch